2型糖尿病成人中握力与椅立试验评估肌少症患病率的差异
本研究基于732例2型糖尿病成人(女性35.7%,年龄64±8岁,BMI 30.7±5.0 kg/m²),采用EWGSOP2定义比较握力(HGS)与椅立试验(CST)评估肌少症患病率。CST较HGS产生更高的可能(31.7% vs. 7.1%)、确诊(5.6% vs. 1.6%)和严重(1.0% vs. 0.3%)肌少症患病率,且CST表现与所有肥胖指标显著相关,而HGS无此关联。
要点
- CST较HGS产生更高的肌少症患病率,两者一致性差。
- CST表现与所有肥胖指标显著相关,HGS无此关联。
- 在2型糖尿病成人中需考虑最合适的肌肉功能评估方法。
核心结论
- 较高肥胖水平可能影响CST表现但不影响HGS,导致2型糖尿病成人肌少症患病率更高。
研究设计与样本
- 横断面研究,使用732例2型糖尿病成人数据(女性35.7%,年龄64±8岁,BMI 30.7±5.0 kg/m²)。
主要发现
- 使用CST相比HGS产生更高的可能肌少症患病率(31.7% vs. 7.1%)。
- 使用CST相比HGS产生更高的确诊肌少症患病率(5.6% vs. 1.6%)。
- 使用CST相比HGS产生更高的严重肌少症患病率(1.0% vs. 0.3%)。
- 两种力量标准识别可能肌少症的一致性差。
- CST表现与所有肥胖指标在未调整和调整模型中均显著相关,而HGS不相关。
关键数值与推荐
- 采用EWGSOP2定义评估可能(低肌肉力量)、确诊(加低肌肉量)和严重(加身体表现差)肌少症。
临床怎么用
- 在2型糖尿病成人中评估肌少症时,应考虑CST与HGS的差异及肥胖对CST的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The updated European Working Group on Sarcopenia in Older People (EWGSOP2) recommends handgrip strength (HGS) and the chair stand test (CST) to assess muscle strength, with the CST being a convenient proxy for lower limb strength. However, adiposity may differentially influence these strength criteria and produce discrepant sarcopenia prevalence. OBJECTIVE: To determine the prevalence of sarcopenia using HGS or the CST, and to investigate the associations between these strength criteria and adiposity in adults with type 2 diabetes mellitus. METHODS: The EWGSOP2 definition was used to assess the prevalence of probable (low muscle strength), confirmed (plus low muscle mass) and severe (plus poor physical performance) sarcopenia. Linear regression models were used to study the association between different measures of muscle strength and adiposity. RESULTS: We used data from 732 adults with type 2 diabetes mellitus (35.7% female, aged 64 ± 8 years, body mass index 30.7 ± 5.0 kg/m2). Using the CST compared with HGS produced a higher prevalence of probable (31.7% vs. 7.1%), confirmed (5.6% vs. 1.6%) and severe (1.0% vs. 0.3%) sarcopenia, with poor agreement between strength criteria to identify probable sarcopenia. CST performance, but not HGS, was significantly associated with all measures of adiposity in unadjusted and adjusted models. CONCLUSIONS: Higher levels of adiposity may impact CST performance, but not HGS, resulting in a higher prevalence of sarcopenia in adults with type 2 diabetes mellitus. Consideration should be paid to the most appropriate measure of muscle function in this population.
引用
- Belfield AE, Wilkinson TJ, Henson J, et al. Sarcopenia prevalence using handgrip strength or chair stand performance in adults living with type 2 diabetes mellitus. Age Ageing. 2024. PMID: 38706394. doi:10.1093/ageing/afae090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。